Medartis to Host Full-Year 2024 Results Conference with Q&A
Medartis will present its full-year 2024 results today at 10:30 a.m. CET at its headquarters in Basel. The new CEO, Matthias Schupp, and CFO, Dirk Kirsten, will host the event. The conference will be held in English.
If you cannot attend in person, use the webcast link to follow the slide presentation and submit questions in writing or via the webcast.
- 20.08.2024 Publication of Medartis 2024 half-year results
- 09.07.2024 Matthias Schupp appointed as CEO of Medartis
- 11.06.2024 Medartis announces resignation of CEO Christoph Brönnimann
- 04.04.2024 Medartis successfully places CHF 115.8 million convertible bonds due 2031
- 03.04.2024 Medartis launches senior convertible bond offering in a private placement
- 12.03.2024 Press release 2023 full-year results
- 15.08.2023 Press release 2023 half-year results
- 17.03.2023 Medartis announces small capital increase
- 16.08.2022 Press release 2022 H1 results
- 03.05.2022 Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership
- 14.03.2023 Press release 2022 full-year results
- 08.04.2022 Press release Medartis not to pursue convertible bond placement
- 07.04.2022 Press release Medartis launches convertible bond offering
- 07.03.2022 Press release 2021 fully year results
- 17.08.2021 Press release 2021 H1 results
- 23.04.2021 Press release 2021 annual general meeting
- 09.03.2021 Press release 2020 full-year results
- 11.12.2020 Medartis appoints Dirk Kirsten as Chief Financial Officer and EMB member
- 01.12.2020 Medartis announces strategic partnership with KeriMedical
- 18.08.2020 Press release 2020 half-year results
- 10.06.2020 Medartis appoints Mareike Loch as Vice President EMEA and EMB Member
- 17.04.2020 Press release extension of EMB, Covid-19 and Annual General Meeting 2020
- 18.03.2020 Medartis nominates Marco Gadola for election to the Board of Directors
- 03.03.2020 Medartis announces 2019 results
- 09.12.2019 Medartis provides information on Brazil investigation
- 01.11.2019 Medartis announces change in executive management
- 20.08.2019 Press release 2019 half-year results
- 27.05.2019 Medartis announces Change of CEO as of 1 September 2019
- 10.05.2019 Voting results 2019 Annual General Meeting
- 10.05.2019 Press release 2019 annual general meeting
- 02.04.2019 Press release 2018 full-year results
- 20.02.2019 Medartis announces preliminary key figures for the 2018 financial year
No results
- 04.02.2025 Invitation Video Webcast: 2024 full year results presentation
- 20.11.2024 Investor's presentation at ZKB and Jefferies conference
- 20.08.2024 Recording of the 2024 Half Year Results Conference Call
- 20.08.2024 Slide presentation of Medartis' half-year results 2024
- 20.08.2024 Half-year report 2024
- 25.07.2024 Invitation Medartis H1 Results 2024
- 17.04.2024 Medartis shareholders approve all proposals at the AGM 2024
- 12.03.2024 Audio Webcast of the 2023 Full Year Results Conference Call
- 12.03.2024 Presentation 2023 full-year results
- 12.03.2024 Corporate Governance Report 2023
- 12.03.2024 Sustainability Report 2023
- 12.03.2024 Remuneration Report 2023
- 12.03.2024 Annual Report 2023
- 22.02.2024 Invitation Audio Webcast: 2023 full year results presentation
- 15.08.2023 Half year Report 2023
- 15.08.2023 Presentation half-year results 2023
- 15.08.2023 Recording of the 2023 Half Year Results Conference Call
- 25.07.2024 Invitation Webcast: Medartis H1 2023 results presentation
- 21.04.2023 Press release 2023 annual general meeting
- 14.03.2023 Recording of the 2022 Full Year Results Conference Call
- 14.03.2023 Presentation 2022 full-year results
- 14.03.2023 Sustainability Report 2022
- 14.03.2023 Remuneration Report 2022
- 14.03.2023 Annual Report 2022
- 16.02.2023 Invitation Webcast: Medartis 2022 full-year results presentation
- 16.08.2022 Recording of telephone conference 2022 half-year results
- 16.08.2022 Presentation half-year results 2022
- 16.08.2022 Financial Report H1 2022
- 27.07.2022 Invitation Webcast: Medartis 2022 half-year results presentation
- 06.04.2022 Press release 2022 annual general meeting
- 07.03.2022 Sustainability at Medartis 2021
- 07.03.2022 Recording of telephone conference 2021 full-year results
- 07.03.2022 Presentation 2021 full-year results
- 07.03.2022 Remuneration Report 2021
- 07.03.2022 Corporate Governance Report 2021
- 07.03.2022 Annual Report 2021
- 17.08.2021 Recording of telephone conference 2021 half-year results
- 17.08.2021 Financial Report H1 2021
- 17.08.2021 Presentation half-year results 2021
- 10.03.2021 Annual Report 2020
- 10.03.2021 Financial Report FY 2020
- 10.03.2021 Remuneration Report 2020
- 10.03.2021 Corporate Governance Report 2020
- 10.03.2021 Recording of telephone conference 2020 full-year results
- 10.03.2021 Presentation 2020 full-year results
No results
- 17.04.2024 Medartis shareholders approve all proposals at the AGM 2024
- 17.04.2024 Voting results 2024 Annual General Meeting (only German)
- 26.03.2024 Invitation 2024 Annual General Meeting
- 26.03.2024 Highlights 2023 Annual Report
- 21.04.2023 Voting results 2023 Annual General Meeting
- 05.04.2023 Changes to the Articles of Association of Medartis Holding AG (German only) – revised
- 30.03.2023 Invitation 2023 Annual General Meeting
- 30.03.2023 Changes to the Articles of Association of Medartis Holding AG (German only) - replaced
- 30.03.2023 Highlights 2022 Annual Report
- 06.04.2022 Voting results 2022 Annual General Meeting
- 15.03.2022 Highlights 2021 Annual Report
- 15.03.2022 Convocation 2022 Annual General Meeting
- 23.04.2021 Voting results 2021 Annual General Meeting
- 29.03.2021 Convocation 2021 Annual General Meeting
- 29.03.2021 Highlights 2020 Annual Report
No results
Share information
Events
Key figures full-year 2023
Net sales in CHFm
212.0
Driven by strong performance in EMEA, LATAM and the US.
Internal growth
17.4%
Sales in 3 out of 4 regions soared in the 20% range.
Underlying EBITDA in CHFm
33.6
EBITDA margin increased from 12.8% to 15.9%.
Subscribe to ad hoc-News
Would you like to be informed about Medartis at first hand? Register and receive our news in electronic form.
Do you have any more questions?
Investor Relations:
investor.relations@medartis.com
Phone: +41 61 633 37 36
Media Relations:
corporate.communication@medartis.com
Phone: +41 61 633 37 34
Postal Address:
Medartis AG
Hochbergerstrasse 60E
CH-4057 Basel
Switzerland